Agilent Technologies Inc
NYSE:A
Agilent Technologies Inc
NYSE:A
Price:
137.4675 USD
0.8%
Updated:
Apr 26, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
6.1
Current
6.2
Median
3.7
Industry
Lower
than median
Higher
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=6.1
Enterprise Value
/
41.1B
Revenue
6.7B
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| US |
|
Agilent Technologies Inc
NYSE:A
|
40.3B USD | 6.1 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.6B USD | 5.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
181.8B USD | 8.1 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.6B USD | 3.6 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.9B CHF | 5.8 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
54.8T KRW | 14.6 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.8B USD | 8.8 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.8B USD | 7.6 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.4B USD | 3.5 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
18.9B EUR | 7.8 | |
| US |
|
Illumina Inc
NASDAQ:ILMN
|
19.4B USD | 4.4 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
5.9
2-Years Forward
EV/S
5.6
3-Years Forward
EV/S
5.2
You don't have any saved screeners yet
